Kenmotsu H, Saito Y, Ninomiya K, Uematsu S, et al. Long-Term Safety and Effectiveness of Durvalumab in Unresectable Stage III non-small cell lung cancer in Japan: A Multicenter Prospective Study (AYAME). J Thorac Oncol 2025 Aug 18:S1556-0864(25)01014.
PMID: 40835220